OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. Together with its wholly owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, OraSure provides its customers with end-to-end solutions that encompass tools, services and diagnostics.
The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions.
OraSure's portfolio of products is sold globally to clinical laboratories, hospitals, physician's offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities, and direct to consumers.
The OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test offers healthcare providers a fast and reliable method for detecting HIV-1 and HIV-2 antibodies, delivering results in just 20 minutes. With over 99% accuracy, this CLIA-waived test can be used with oral fluid, plasma, fingerstick, or venipuncture whole blood specimens, making it ideal for both clinical and non-clinical settings. Its simple and flexible design allows for easy integration into various testing environments, including outreach programs and mobile clinics. By providing pain-free, needle-free testing, the OraQuick ADVANCE® enables more individuals to be screened and promptly connected to care, enhancing the overall effectiveness of HIV prevention and treatment efforts.
Product Ordering and Details
The OraQuick® In-Home HIV Test is a groundbreaking solution, being the first and only FDA-approved oral fluid rapid HIV test available over-the-counter in the U.S. This innovative test allows individuals to detect both HIV-1 and HIV-2 antibodies with a simple oral swab, delivering results in just 20 minutes. Designed for privacy and ease, the OraQuick® test offers a convenient at-home testing option, complete with extensive support resources. Users benefit from access to a dedicated toll-free customer support center and a comprehensive online platform, ensuring they have the guidance needed throughout the testing process.
The Intercept® Oral Fluid Collection Device offers an FDA-cleared solution for accurate drug testing, detecting substances such as marijuana, cocaine, PCP, amphetamines, and opiates. This laboratory-based system is easy to administer, making it an ideal choice for workplace drug testing, criminal justice applications, drug treatment centers, and clinical settings. With The Intercept®, you can count on reliable results and a straightforward collection process, ensuring efficient and effective screening for drugs of abuse.
Introducing the OraSure Technologies Intercept® i2he® Oral Fluid Collection Device, designed exclusively for forensic use by trained professionals. This advanced device ensures the reliable collection, preservation, and transport of oral fluid samples with precision. Featuring a volume adequacy indicator and a robust collection pad. The ergonomic design and quick 3-minute collection time offer ease and convenience, while the increased sample volume and stability at higher temperatures guarantee superior performance and consistent drug recovery. Trust the Intercept® i2he® for confident and efficient oral fluid collection in your professional practice.
The Intercept® i2 Oral Fluid Collection Device simplifies and streamlines in-office drug testing. This FDA-cleared device features a collection pad with a built-in volume adequacy indicator, ensuring you obtain a sufficient sample every time. The ergonomic design and easy-to-use collection process enhance patient comfort and clinician experience. The Intercept® i2 allows for rapid testing with a variety of drug panels, providing you with accurate results to support informed patient care decisions.
The Q.E.D.® Saliva Alcohol Test offers a quick, cost-effective solution for on-site alcohol testing, providing accurate, quantitative results in under five minutes using just a saliva sample. This CLIA-waived and Department of Transportation-approved test delivers results comparable to blood-based tests, with a clear, easy-to-read thermometer-like display. Designed for ease of use, the built-in QA Spot™ ensures proper specimen application and quality control. Ideal for healthcare settings, this low-cost alternative to traditional breath or blood tests can be administered by any trained professional, offering reliable and efficient alcohol testing.
The OraQuick® HCV Test is the first FDA-approved, CLIA-waived rapid test for detecting HCV antibodies using fingerstick and venipuncture whole blood samples. This test offers healthcare providers a quick and accurate diagnosis within 20 minutes, boasting over 98% accuracy. Ideal for use in various settings such as public health facilities, physician's offices, community health clinics, laboratories, and emergency rooms, the OraQuick® HCV Test ensures reliable, point-of-care results. Its easy-to-use platform and ability to test for multiple HCV genotypes make it a valuable tool for efficient and effective hepatitis C screening.
The Diagnostics Direct Syphilis Health Check™ offers a rapid and reliable solution for syphilis testing, delivering results in just 10 minutes. This CLIA-waived test is designed for fingerstick whole blood samples and is suitable for both clinical and non-clinical settings, including outreach programs and mobile clinics. With an accuracy of 98.0% sensitivity and 97.2% specificity, it effectively detects IgM and IgG antibodies. The simple, easy-to-read format requires no additional equipment, streamlining the testing process and allowing more patients to be tested efficiently. This test is accessible for individuals aged 13 and older and has been proven to detect syphilis at all stages of infection, including latent stages, making it an essential tool for early diagnosis and prompt connection to care.
The InteliSwab® COVID-19 Rapid Test provides a quick and efficient solution for COVID-19 detection, now available with Emergency Use Authorization from the FDA. Designed for professional use in point-of-care CLIA-waived settings, the InteliSwab® test is incredibly simple, utilizing a built-in swab that integrates directly into the test stick. After self-collecting a sample from the lower nostrils, users swirl the test stick in a pre-measured buffer solution, and results appear on the test stick within 30 minutes. This rapid antigen test requires no additional instruments, batteries, or laboratory analysis, making it an ideal choice for healthcare providers seeking reliable and immediate COVID-19 testing.
Learn more about OraSure Technologies
OraQuick and OraQuick ADVANCE are registered trademarks of OraSure Technologies, Inc. Syphilis Health Check is a trademark of Diagnostics Direct LLC, used under license by OraSure Technologies, Inc. Syphilis Health Check products are manufactured by Diagnostics Direct, LLC, and distributed by OraSure Technologies, Inc., © 2024 OraSure Technologies, Inc., all rights reserved.